Infliximab for Treatment-Refractory Transverse Myelitis Following Immune Therapy and Radiation
Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1186/s40425-018-0471-2
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2018
Authors
Publisher
BMJ